AlzeCure Pharma begins patient dosing in phase II trial in neuropathic pain with non-opioid ACD440
By, Admin1 min read
Share
AlzeCure Pharma AB (publ), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
